FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079870323> ?p ?o ?g. }

• W2079870323 endingPage "696" @default.
• W2079870323 startingPage "694" @default.
• W2079870323 abstract "Osteoporosis is a progressive systemic skeletal disease, in which the equilibrium of bone resorption and bone formation is disturbed. The drugs for osteoporosis can be divided into two categories according to their predominant effects: antiresorptive drugs and anabolic drugs. Antiresorptive drugs are designed to inhibit bone resorption and anabolic drugs are aiming to stimulate bone formation. On the other hand, most antiresorptive drugs usually decrease anabolic activities and reduce bone formation, while anabolic drugs can unintendedly increase bone resorption. Furthermore, both types of drugs show no preferential distribution in bone and can locate generally in the areas of both bone formation and bone resorption. Consequently, the non-specific interaction of these drugs with non-targeting area and cells can lead to a compromised efficacy. Combined therapies of antiresorptive and anabolic drugs do not necessarily yield superiority when compared to monotherapy. Here, basing on the targeting cells of these two kinds of drugs and the spatial distribution of osteoblasts and osteoclasts, we propose a novel drug delivery system of bi-directionally selective targeting in order to facilitate the efficacy of antiresorptive and anabolic drugs in combined therapy. In the system, an antiresorptive drug will be linked with a peptide of the eight repeating sequences of aspartate--(Asp)8 that can preferentially guide the drugs to bone resorption zone; while an anabolic drug linked with a peptide of six repeats of the sequence aspartate, serine, serine--(Asp-Ser-Ser)6 that can favorably guide the drugs to bone formation zone. The novel delivery system will improve the specific interaction between the drugs and their targeting cells. Furthermore, the system will reduce the non-specific interaction of the anabolic and antiresorptive drugs with their respective non-targeting cells, which will maximally reduce their side-effects. Therefore, we postulate that the new bone targeting drug delivery system will be a blessing for osteoporotic patients." @default.
• W2079870323 created "2016-06-24" @default.
• W2079870323 creator A5000255071 @default.
• W2079870323 creator A5006094386 @default.
• W2079870323 creator A5007031430 @default.
• W2079870323 creator A5023252191 @default.
• W2079870323 creator A5039141559 @default.
• W2079870323 creator A5068951778 @default.
• W2079870323 creator A5073948949 @default.
• W2079870323 creator A5082661675 @default.
• W2079870323 date "2014-12-01" @default.
• W2079870323 modified "2023-10-14" @default.
• W2079870323 title "Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: A novel combined therapy for osteoporosis?" @default.
• W2079870323 cites W1519536427 @default.
• W2079870323 cites W1966865004 @default.
• W2079870323 cites W1973531794 @default.
• W2079870323 cites W1981602322 @default.
• W2079870323 cites W1995349540 @default.
• W2079870323 cites W1998464768 @default.
• W2079870323 cites W2006804772 @default.
• W2079870323 cites W2013599591 @default.
• W2079870323 cites W2040818940 @default.
• W2079870323 cites W2041578222 @default.
• W2079870323 cites W2043007466 @default.
• W2079870323 cites W2045068208 @default.
• W2079870323 cites W2059857909 @default.
• W2079870323 cites W2063185156 @default.
• W2079870323 cites W2086035454 @default.
• W2079870323 cites W2103502150 @default.
• W2079870323 cites W2110957675 @default.
• W2079870323 cites W2113162921 @default.
• W2079870323 cites W2138829214 @default.
• W2079870323 cites W2145733834 @default.
• W2079870323 cites W2396798113 @default.
• W2079870323 doi "https://doi.org/10.1016/j.mehy.2014.09.020" @default.
• W2079870323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25459136" @default.
• W2079870323 hasPublicationYear "2014" @default.
• W2079870323 type Work @default.
• W2079870323 sameAs 2079870323 @default.
• W2079870323 citedByCount "7" @default.
• W2079870323 countsByYear W20798703232015 @default.
• W2079870323 countsByYear W20798703232016 @default.
• W2079870323 countsByYear W20798703232020 @default.
• W2079870323 countsByYear W20798703232021 @default.
• W2079870323 countsByYear W20798703232023 @default.
• W2079870323 crossrefType "journal-article" @default.
• W2079870323 hasAuthorship W2079870323A5000255071 @default.
• W2079870323 hasAuthorship W2079870323A5006094386 @default.
• W2079870323 hasAuthorship W2079870323A5007031430 @default.
• W2079870323 hasAuthorship W2079870323A5023252191 @default.
• W2079870323 hasAuthorship W2079870323A5039141559 @default.
• W2079870323 hasAuthorship W2079870323A5068951778 @default.
• W2079870323 hasAuthorship W2079870323A5073948949 @default.
• W2079870323 hasAuthorship W2079870323A5082661675 @default.
• W2079870323 hasConcept C1008401 @default.
• W2079870323 hasConcept C126322002 @default.
• W2079870323 hasConcept C146562846 @default.
• W2079870323 hasConcept C185592680 @default.
• W2079870323 hasConcept C2776169692 @default.
• W2079870323 hasConcept C2776541429 @default.
• W2079870323 hasConcept C2780035454 @default.
• W2079870323 hasConcept C2910186798 @default.
• W2079870323 hasConcept C673006 @default.
• W2079870323 hasConcept C71924100 @default.
• W2079870323 hasConcept C98274493 @default.
• W2079870323 hasConceptScore W2079870323C1008401 @default.
• W2079870323 hasConceptScore W2079870323C126322002 @default.
• W2079870323 hasConceptScore W2079870323C146562846 @default.
• W2079870323 hasConceptScore W2079870323C185592680 @default.
• W2079870323 hasConceptScore W2079870323C2776169692 @default.
• W2079870323 hasConceptScore W2079870323C2776541429 @default.
• W2079870323 hasConceptScore W2079870323C2780035454 @default.
• W2079870323 hasConceptScore W2079870323C2910186798 @default.
• W2079870323 hasConceptScore W2079870323C673006 @default.
• W2079870323 hasConceptScore W2079870323C71924100 @default.
• W2079870323 hasConceptScore W2079870323C98274493 @default.
• W2079870323 hasFunder F4320321001 @default.
• W2079870323 hasFunder F4320338464 @default.
• W2079870323 hasIssue "6" @default.
• W2079870323 hasLocation W20798703231 @default.
• W2079870323 hasLocation W20798703232 @default.
• W2079870323 hasOpenAccess W2079870323 @default.
• W2079870323 hasPrimaryLocation W20798703231 @default.
• W2079870323 hasRelatedWork W1973067746 @default.
• W2079870323 hasRelatedWork W2035923614 @default.
• W2079870323 hasRelatedWork W2080039269 @default.
• W2079870323 hasRelatedWork W2090278215 @default.
• W2079870323 hasRelatedWork W2123649103 @default.
• W2079870323 hasRelatedWork W2129413256 @default.
• W2079870323 hasRelatedWork W2134655428 @default.
• W2079870323 hasRelatedWork W2163477169 @default.
• W2079870323 hasRelatedWork W2615962624 @default.
• W2079870323 hasRelatedWork W2183106306 @default.
• W2079870323 hasVolume "83" @default.
• W2079870323 isParatext "false" @default.
• W2079870323 isRetracted "false" @default.
• W2079870323 magId "2079870323" @default.
• W2079870323 workType "article" @default.